Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
CNY 8.04
(1.9%)
CNY 8.04
(1.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -540.91 Million CNY | 24.98% |
| 2022 | -721.02 Million CNY | -226.31% |
| 2021 | 570.83 Million CNY | 22.63% |
| 2020 | 465.5 Million CNY | -44.16% |
| 2019 | 833.68 Million CNY | -7.6% |
| 2018 | 902.3 Million CNY | 2.45% |
| 2017 | 880.69 Million CNY | 77.15% |
| 2016 | 497.13 Million CNY | 18.53% |
| 2015 | 419.4 Million CNY | 3516.8% |
| 2014 | -12.27 Million CNY | 86.45% |
| 2013 | -90.6 Million CNY | -11.27% |
| 2012 | -81.42 Million CNY | -43.67% |
| 2011 | -56.67 Million CNY | -162.64% |
| 2010 | -21.57 Million CNY | -811.39% |
| 2009 | 3.03 Million CNY | -54.45% |
| 2008 | 6.65 Million CNY | 151.01% |
| 2007 | -13.05 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -356.21 Million CNY | 17.87% |
| 2024 Q3 | -409.85 Million CNY | -15.06% |
| 2024 Q1 | -433.71 Million CNY | 19.82% |
| 2023 FY | -540.91 Million CNY | 24.98% |
| 2023 Q4 | -540.91 Million CNY | 4.17% |
| 2023 Q2 | -974.64 Million CNY | -26.05% |
| 2023 Q1 | -773.22 Million CNY | -7.24% |
| 2023 Q3 | -564.46 Million CNY | 42.09% |
| 2022 Q3 | -829.61 Million CNY | 13.93% |
| 2022 Q2 | -963.83 Million CNY | -416.72% |
| 2022 Q1 | 304.32 Million CNY | -46.69% |
| 2022 FY | -721.02 Million CNY | -226.31% |
| 2022 Q4 | -721.02 Million CNY | 13.09% |
| 2021 Q3 | 690.29 Million CNY | 15.0% |
| 2021 Q2 | 600.26 Million CNY | 24.76% |
| 2021 Q1 | 481.13 Million CNY | 3.36% |
| 2021 FY | 570.83 Million CNY | 22.63% |
| 2021 Q4 | 570.83 Million CNY | -17.31% |
| 2020 Q3 | 622.13 Million CNY | -1.79% |
| 2020 Q1 | 770.15 Million CNY | -7.62% |
| 2020 FY | 465.5 Million CNY | -44.16% |
| 2020 Q2 | 633.47 Million CNY | -17.75% |
| 2020 Q4 | 465.5 Million CNY | -25.18% |
| 2019 FY | 833.68 Million CNY | -7.6% |
| 2019 Q1 | 1.12 Billion CNY | 25.21% |
| 2019 Q2 | 1.06 Billion CNY | -5.63% |
| 2019 Q4 | 833.68 Million CNY | -13.05% |
| 2019 Q3 | 958.78 Million CNY | -10.07% |
| 2018 Q2 | 985.87 Million CNY | -0.58% |
| 2018 Q3 | 1.02 Billion CNY | 4.1% |
| 2018 FY | 902.3 Million CNY | 2.45% |
| 2018 Q4 | 902.3 Million CNY | -12.08% |
| 2018 Q1 | 991.63 Million CNY | 12.6% |
| 2017 Q4 | 880.69 Million CNY | 13.22% |
| 2017 Q2 | 688.8 Million CNY | 16.76% |
| 2017 Q1 | 589.93 Million CNY | 18.67% |
| 2017 FY | 880.69 Million CNY | 77.15% |
| 2017 Q3 | 777.84 Million CNY | 12.93% |
| 2016 Q3 | 362.71 Million CNY | 79.03% |
| 2016 Q2 | 202.6 Million CNY | -67.0% |
| 2016 FY | 497.13 Million CNY | 18.53% |
| 2016 Q1 | 614.02 Million CNY | 46.4% |
| 2016 Q4 | 497.13 Million CNY | 37.06% |
| 2015 Q2 | -20.16 Million CNY | -637.73% |
| 2015 FY | 419.4 Million CNY | 3516.8% |
| 2015 Q4 | 419.4 Million CNY | 797.86% |
| 2015 Q3 | 46.71 Million CNY | 331.6% |
| 2015 Q1 | 3.75 Million CNY | 130.56% |
| 2014 Q2 | -208.77 Million CNY | 9.06% |
| 2014 Q1 | -229.56 Million CNY | -153.39% |
| 2014 Q4 | -12.27 Million CNY | 94.17% |
| 2014 Q3 | -210.42 Million CNY | -0.79% |
| 2014 FY | -12.27 Million CNY | 86.45% |
| 2013 Q4 | -90.6 Million CNY | 0.0% |
| 2013 FY | -90.6 Million CNY | -11.27% |
| 2013 Q1 | 81.42 Million CNY | 200.0% |
| 2013 Q2 | -69.72 Million CNY | -185.64% |
| 2013 Q3 | - CNY | 100.0% |
| 2012 Q4 | -81.42 Million CNY | 0.0% |
| 2012 FY | -81.42 Million CNY | -43.67% |
| 2011 FY | -56.67 Million CNY | -162.64% |
| 2010 Q3 | 14.17 Million CNY | 0.0% |
| 2010 FY | -21.57 Million CNY | -811.39% |
| 2010 Q4 | -21.57 Million CNY | -252.19% |
| 2009 FY | 3.03 Million CNY | -54.45% |
| 2008 FY | 6.65 Million CNY | 151.01% |
| 2007 FY | -13.05 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Lifecome Biochemistry Co.,Ltd. | 878.34 Million CNY | 161.584% |
| Chengdu Kanghua Biological Products Co., Ltd. | -844.61 Million CNY | 35.957% |
| NanHua Bio-medicine Co., Ltd | -449.53 Million CNY | -20.328% |
| Shandong Sito Bio-technology Co., Ltd. | 553.09 Million CNY | 197.798% |
| Porton Pharma Solutions Ltd. | 242.94 Million CNY | 322.649% |
| Zhejiang Wecome Pharmaceutical Company Limited | 105.08 Million CNY | 614.76% |